期刊文献+

心功能检查在慢性肾脏病患者血管通路术前评估的研究进展 被引量:3

Progress in the research of cardiac function test for preoperative assessment of vascular access in patients with chronic kidney disease
下载PDF
导出
摘要 血液透析血管通路是终末期肾病血液透析患者的生命线。慢性肾脏病患者往往伴有不同程度的心血管疾病,可增加血管通路手术的围手术期风险,并影响长期预后。血管通路术前应详细评价患者心脏功能及储备能力,根据患者综合情况选择恰当的血管通路策略,以为临床治疗提供更多参考,现就研究进展综述如下。 Hemodialysis vascular access is a life line for hemodialysis patients with end-stage renal disease. Patients with chronic kidney disease are often associated with various degrees of cardiovascular disease,which increases the perioperative risk of vascular access surgery and affects long-term outcomes. Cardiac function and its reserved capacity should be evaluated in detail before vascular access surgery. To provide references for clinical treatment, appropriate vascular access strategy should be selected according to the comprehensive situations of the patients. The research progress about this issue is summarized in this review.
作者 马慧超 于洋 崔天蕾 付平 MA Hui-chao;YU Yang;CUI Tian-lei;FU Ping(Department of Nephrology,West China Kidney Disease Research Laboratory,West China Hospital,Sichuan University,Chengdu 600041,China)
出处 《中国血液净化》 CSCD 2019年第1期50-53,共4页 Chinese Journal of Blood Purification
关键词 慢性肾脏病 肾透析 血液透析 血管通路 心功能评价 术前评估 Chronic kidney disease Dialysis Hemodialysis Vascular access Cardiac assessment Preoperative assessment
  • 相关文献

参考文献7

二级参考文献55

  • 1赵雪燕,杨跃进,张健,党爱民,倪新海,黄洁,康晟,马卫华,赵冬云.B型利钠肽在诊断左心衰竭中的价值[J].中华医学杂志,2006,86(17):1165-1169. 被引量:97
  • 2陈国伟 郑宗锷.现代心脏内科学[M].湖南科学技术出版社,1996.908-921.
  • 3肾脏病与透析肾移植杂志,2003,4:176-179.
  • 4Tamura K,Takahashi N, Nakatani Y, et al. Prognostic impact of plasma brain natriuretic peptide for cardiac events in elderly patients with congestive heart failure. Geronto Logy, 2001,47 ( 1 ) :46-51.
  • 5Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction:comparison with Doppler velocity recordings. Circulation ,2002,105 ( 5 ) :595-601.
  • 6Emdin M, Passino C, Prontera C, et al. Comparison of brain natriuretic peptide(BNP) and amino-terminal ProBNP for early diagnosis of heart failure. Clin Chem ,2007,53 ( 7 ) : 1289-1297.
  • 7Doust JA, Pietrzak E, Dobson A, et al. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure : systematic review. BMJ ,2005,330(7492 ) :625.
  • 8Bolger AP, Sharma R, Li W, et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation ,2002,106( 1 ) :92-99.
  • 9Logeart D, Thabut G, Jourdain P, et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coil Cardiol,2004 ,43 (4) :635-641.
  • 10Daniels LB, Maisel AS. Natriuretic peptides,J AM Coll Cardiol,2007, 50(25 ) :2357-2368.

共引文献697

同被引文献30

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部